Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Progress in islet transplantation is more important than ever

Nature Reviews Endocrinology volume 18, pages 389–390 (2022)Cite this article

Subjects

It is increasingly clear that pancreatic islet replacement is needed to provide a comprehensive treatment for the growing numbers of patients with type 1 diabetes mellitus. Advances from the past year suggest that this goal might now be within reach.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Walker, J. T., Saunders, D. C., Brissova, M. & Powers, A. C. The human islet: mini-organ with mega-impact. Endocr. Rev. 42, 605–657 (2021).

    Article  Google Scholar 

  2. Lin, Y. K., Fisher, S. J. & Pop-Busui, R. Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies. J. Diabetes Investig. 11, 1388–1402 (2020).

    Article  Google Scholar 

  3. Krentz, N. A. J., Shea, L. D., Huising, M. O. & Shaw, J. A. M. Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering. Lancet Diabetes Endocrinol. 9, 708–724 (2021).

    Article  CAS  Google Scholar 

  4. Richardson, S. J. & Pugliese, A. 100 years of insulin: Pancreas pathology in type 1 diabetes: an evolving story. J. Endocrinol. 252, R41–R57 (2021).

    Article  Google Scholar 

  5. Steenblock, C. et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 9, 786–798 (2021).

    Article  CAS  Google Scholar 

  6. Ramzy, A. et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell 28, 2047–2061.e5 (2021).

    Article  CAS  Google Scholar 

  7. Shapiro, A. M. J. et al. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Rep Med 2, 100466 (2021).

    Article  Google Scholar 

  8. Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes. Buisiness wire https://www.businesswire.com/news/home/20211018005226/en/ (2021).

  9. Ludwig, B. et al. Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. Proc. Natl. Acad. Sci. USA 114, 11745–11750 (2017).

    Article  CAS  Google Scholar 

  10. Reardon, S. First pig-to-human heart transplant: what can scientists learn? Nature 601, 305–306 (2022).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

    Stefan R. Bornstein, Barbara Ludwig & Charlotte Steenblock

  2. Paul Langerhans Institute Dresden (PLID), Helmholtz Center Munich, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

    Stefan R. Bornstein & Barbara Ludwig

  3. German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany

    Stefan R. Bornstein, Barbara Ludwig & Charlotte Steenblock

  4. Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland

    Stefan R. Bornstein & Barbara Ludwig

  5. School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK

    Stefan R. Bornstein

  6. DFG-Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany

    Barbara Ludwig

Authors
  1. Stefan R. Bornstein
    View author publications

    Search author on:PubMed Google Scholar

  2. Barbara Ludwig
    View author publications

    Search author on:PubMed Google Scholar

  3. Charlotte Steenblock
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Stefan R. Bornstein.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Related links

CDC: https://www.cdc.gov

CoviDIAB: https://covidiab.e-dendrite.com

Diabetes Atlas: https://diabetesatlas.org/

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bornstein, S.R., Ludwig, B. & Steenblock, C. Progress in islet transplantation is more important than ever. Nat Rev Endocrinol 18, 389–390 (2022). https://doi.org/10.1038/s41574-022-00689-0

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41574-022-00689-0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing